Atherosclerosis: From Pathogenesis to Treatment and Outcomes
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 3834
Special Issue Editor
2. Department of General and Medical Genetics, Pirogov Russian National Research Medical University, Moscow, Russia
Interests: cardiology; atherosclerosis; familial hypercholesterolemia; noncompact cardiomyopathy; genetic testing
Special Issue Information
Dear Colleagues,
Research in the field of atherosclerosis has been actively carried out for over 150 years. However, there are currently black holes in our knowledge of the disease. This Special Issue of the Journal of Personalized Medicine aims to show some of the latest findings in the field of atherosclerosis. We invite researchers in this field to submit original research and review articles, including studies on the discovery of novel biomarkers (including genetic and epigenetic biomarkers) and new targets for therapeutic interventions; assessment of the treatment efficacy and outcomes in patients with different genetic forms of monogenic dyslipidemia; the contribution of the microbiome to disease development. Scientific advances in the field of atherosclerosis will provide the path towards developing personalized medicine.
Dr. Alexey N. Meshkov
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atherosclerosis
- biomarkers
- molecular genetic
- monogenic dyslipidemias
- epigenetics
- microbiome
- treatment
- outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
